Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction. (Q47783305)
Jump to navigation
Jump to search
scientific article published on 25 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction. |
scientific article published on 25 March 2016 |
Statements
1 reference
Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction. (English)
1 reference
John J Lepore
1 reference
Eric Olson
1 reference
Laura Demopoulos
1 reference
Thomas Haws
1 reference
Zixing Fang
1 reference
April M Barbour
1 reference
Michael Fossler
1 reference
Victor G Davila-Roman
1 reference
Stuart D Russell
1 reference
Robert J Gropler
1 reference
25 March 2016
1 reference
1 reference
4
1 reference
559-566
1 reference
7
1 reference
Identifiers
1 reference
1 reference